These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17349284)

  • 1. [Calreticulin dictates the immunogenicity of anti-cancer chemotherapy and radiotherapy].
    Apetoh L; Ghiringhelli F; Zitvogel L
    Med Sci (Paris); 2007 Mar; 23(3):257-8. PubMed ID: 17349284
    [No Abstract]   [Full Text] [Related]  

  • 2. Calreticulin exposure increases cancer immunogenicity.
    Clarke C; Smyth MJ
    Nat Biotechnol; 2007 Feb; 25(2):192-3. PubMed ID: 17287754
    [No Abstract]   [Full Text] [Related]  

  • 3. Calreticulin exposure dictates the immunogenicity of cancer cell death.
    Obeid M; Tesniere A; Ghiringhelli F; Fimia GM; Apetoh L; Perfettini JL; Castedo M; Mignot G; Panaretakis T; Casares N; Métivier D; Larochette N; van Endert P; Ciccosanti F; Piacentini M; Zitvogel L; Kroemer G
    Nat Med; 2007 Jan; 13(1):54-61. PubMed ID: 17187072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 'good death' for tumor immunology.
    Storkus WJ; Falo LD
    Nat Med; 2007 Jan; 13(1):28-30. PubMed ID: 17206130
    [No Abstract]   [Full Text] [Related]  

  • 5. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.
    Michaud M; Martins I; Sukkurwala AQ; Adjemian S; Ma Y; Pellegatti P; Shen S; Kepp O; Scoazec M; Mignot G; Rello-Varona S; Tailler M; Menger L; Vacchelli E; Galluzzi L; Ghiringhelli F; di Virgilio F; Zitvogel L; Kroemer G
    Science; 2011 Dec; 334(6062):1573-7. PubMed ID: 22174255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Witch hunt against tumor cells enhanced by dendritic cells.
    Locher C; Rusakiewicz S; Tesnière A; Ghiringhelli F; Apetoh L; Kroemer G; Zitvogel L
    Ann N Y Acad Sci; 2009 Sep; 1174():51-60. PubMed ID: 19769736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to improve the immunogenicity of chemotherapy and radiotherapy.
    Ma Y; Conforti R; Aymeric L; Locher C; Kepp O; Kroemer G; Zitvogel L
    Cancer Metastasis Rev; 2011 Mar; 30(1):71-82. PubMed ID: 21298323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characteristics of immunogenic cancer cell death.
    Tesniere A; Panaretakis T; Kepp O; Apetoh L; Ghiringhelli F; Zitvogel L; Kroemer G
    Cell Death Differ; 2008 Jan; 15(1):3-12. PubMed ID: 18007663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic cancer cell death: a key-lock paradigm.
    Tesniere A; Apetoh L; Ghiringhelli F; Joza N; Panaretakis T; Kepp O; Schlemmer F; Zitvogel L; Kroemer G
    Curr Opin Immunol; 2008 Oct; 20(5):504-11. PubMed ID: 18573340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ecto-calreticulin in immunogenic chemotherapy.
    Obeid M; Tesniere A; Panaretakis T; Tufi R; Joza N; van Endert P; Ghiringhelli F; Apetoh L; Chaput N; Flament C; Ullrich E; de Botton S; Zitvogel L; Kroemer G
    Immunol Rev; 2007 Dec; 220():22-34. PubMed ID: 17979837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anticancer drugs on the immune system in humans.
    Ehrke MJ; Mihich E; Berd D; Mastrangelo MJ
    Semin Oncol; 1989 Jun; 16(3):230-53. PubMed ID: 2658084
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antitumoral immunization during cancer chemotherapy].
    Zitvogel L; Hannani D; Aymeric L; Kepp O; Martins I; Kroemer G
    Bull Acad Natl Med; 2012 Jun; 196(6):1075-86. PubMed ID: 23596856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune system--is it relevant to cancer development, progression and treatment?
    Prestwich RJ; Errington F; Hatfield P; Merrick AE; Ilett EJ; Selby PJ; Melcher AA
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):101-12. PubMed ID: 18037277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve immunotherapy drugs that could cure cancers.
    Cheever MA
    Immunol Rev; 2008 Apr; 222():357-68. PubMed ID: 18364014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells.
    Apetoh L; Obeid M; Tesniere A; Ghiringhelli F; Fimia GM; Piacentini M; Kroemer G; Zitvogel L
    Cancer Genomics Proteomics; 2007; 4(2):65-70. PubMed ID: 17804868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological aspects of cancer chemotherapy.
    Zitvogel L; Apetoh L; Ghiringhelli F; Kroemer G
    Nat Rev Immunol; 2008 Jan; 8(1):59-73. PubMed ID: 18097448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Links between innate and cognate tumor immunity.
    Ghiringhelli F; Apetoh L; Housseau F; Kroemer G; Zitvogel L
    Curr Opin Immunol; 2007 Apr; 19(2):224-31. PubMed ID: 17303400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced induction of anti-tumor immunity in human and mouse by dendritic cells pulsed with recombinant TAT fused human survivin protein.
    Cho HI; Kim EK; Park SY; Lee SK; Hong YK; Kim TG
    Cancer Lett; 2007 Dec; 258(2):189-98. PubMed ID: 17931768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.